Select from the topics above to view the information.
Keith D. Lindor, MD Executive Vice Provost, Health Solutions Professor
MD - Mayo Medical School, MN, 1979
BS - University of Minnesota, MN, 1975 Chemistry
Sinakos E, Abbas G, Jorgensen RA, Lindor KD. Serum lipids in primary sclerosing cholangitis. Dig Liver Dis. 2012 Jan; 44(1):44-8. Epub 2011 Sep 03. PMID:21890438. DOI:10.1016/j.dld.2011.07.020.(Peer-reviewed Article)
Lindor KD, Levy C. Primary biliary cirrhosis. In: Boyer TD; Manns MP; Sanyal AJ editor. Zakim and Boyer's hepatology: a textbook of liver disease. 6th Edition. Philadelphia: Saunders/Elsevier; 2012. p. 738-53. (Book chapter)
Silveira MG, Lindor KD. Primary sclerosing cholangitis. In: Monga SPS editor. Molecular pathology of liver diseases. Volume 5. New York: Springer; 2011. (Molecular Pathology Library Series.). p. 741-52. (Book chapter)
Martin CR, Blanco PG, Keach JC, Petz JL, Zaman MM, Bhaskar KR, Cluette-Brown JE, Gautam S, Sheth S, Afdhal NH, Lindor KD, Freedman SD. The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study. Aliment Pharmacol Ther. 2012 Jan; 35(2):255-65. Epub 2011 Nov 30. PMID:22129201. DOI:10.1111/j.1365-2036.2011.04926.x.(Peer-reviewed Article)
Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011 Nov; 54(5):1842-52. PMID:21793028. PMCID:3205332. NIHMS:312954. DOI:10.1002/hep.24570.(Peer-reviewed Article>
Current/Recent Grants and Projects
Multicentered Randomized Trial of High-dose Urso in PSC (Principal Investigator). Funded by National Institute of Diabetes and Digestive and Kidney Diseases, August 2007-July 2012 (R01 DK 56924).
Prognosis of Nonalcoholic Fatty Liver Disease (Principal Investigator). Funded by National Institute of Diabetes and Digestive and Kidney Diseases, September 2009-August 2012 (R01 DK 82426).
Modafinil in the Treatment of Fatigue in Patients with Primary Biliary Cirrhosis (Principal Investigator). Funded by American College of Gastroenterology, July 2009-September 2010.
Antibiotic treatment in Patients with PSC (Principal Investigator). Funded by PSC Partners Seeking A Cure Foundation, January 2010-December 2010.
A Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO, UDCA) in Patients with Primary Biliary Cirrhosis (Principal Investigator). Funded by Intercept, October 2007-December 2009.
Carol M. Gatton Professor of Digestive Disease Research, Mayo Clinic, 2010
Internal Named Professor - Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 2007